Arch Oncology competitorsClear all

Arch Oncology's top competitors include Tollys and Apexigen.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
Arch Oncology
Arch Oncology
Arch Oncology is a clinical-stage immuno-oncology company focused on the discovery and development of antibody therapies for the treatment of patients with cancer.
Tollys
Tollys
Tollys is a biopharmaceutical company focused on innate immunity, particularly on the biology and modulation of the TLR3 receptor.
Apexigen
Apexigen
Apexigen is a company that develops antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology.
Founding Date
Founding Date
2006
Founding Date
2015
Founding Date
2010
Type
Type
Private
Type
Private
Type
Private
Tags
Locations
Locations
Brisbane, US HQ
St. Louis, US
Locations
Lyon, FR HQ
Lyon, FR
Locations
San Carlos, US HQ
Employees
Employees
413% increase
Employees
N/A
Employees
365% decrease
Alexa Website Rank
Alexa Website Rank
143845
Alexa Website Rank
N/A
Alexa Website Rank
148563
Employee Rating
Employee Rating
4
Employee Rating
N/A
Employee Rating
3.8

Funding

Latest funding round
Latest funding round
$ 105m (about 1 year ago)
Latest funding round
$ 2.5m (about 2 years ago)
Latest funding round
$ 65m (about 2 years ago)
Total funding raised
Total funding raised
$ 155m
Total funding raised
$ 6.8m
Total funding raised
$ 158m
For sources of this data, please see the company profile

View company profiles

Tollys
HQ
Lyon, FR

Tollys is a biopharmaceutical company focused on innate immunity, particularly on the biology and modulation of the TLR3 receptor.

View company
Apexigen
HQ
San Carlos, US
Employees
36↓ 5% decrease

Apexigen is a company that develops antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology.

View company